Kenneth Galbraith

CIK 1567045 · View on SEC EDGAR ↗

Insider

First SEC filing: Oct. 9, 2013 · Latest: Oct. 9, 2013

On this page

Insider at

Insider transactions

0 buys (P) 4 sells (S) Net: $-3,337,929 + 43 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

43 other filings hidden
Date Ticker Code Shares Price Value Owned after Δ own A/D vs now
Jan. 12, 2026 ZYME S 30,424 $22.67 $689,712 226,842 Direct -11.83% Disposed 22.2% (price as of 2026-08-19)
Jan. 5, 2026 ZYME S 31,686 $25.10 $795,319 193,266 Direct -14.09% Disposed 10.3% (price as of 2026-08-19)
Jan. 5, 2026 ZYME S 22,657 $25.10 $568,691 158,286 Direct -12.52% Disposed 10.3% (price as of 2026-08-19)
Dec. 22, 2025 ZYME S 47,528 $27.02 $1,284,207 133,275 Direct -26.29% Disposed 2.5% (price as of 2026-08-19)
Jan. 6, 2025 ZYME S 33,406 $14.92 $498,418 80,803 Direct -29.25% Disposed 85.6% (price as of 2026-08-19)
Jan. 6, 2025 ZYME S 23,885 $14.92 $356,364 47,543 Direct -33.44% Disposed 85.6% (price as of 2026-08-19)
Jan. 8, 2024 ZYME S 5,706 $11.22 $64,021 23,762 Direct -19.36% Disposed 146.8% (price as of 2026-08-19)
Jan. 5, 2024 ZYME S 18,198 $10.65 $193,809 29,468 Direct -38.18% Disposed 160.1% (price as of 2026-08-19)
Sept. 9, 2020 MGNX S 13,849 $27.11 $375,446 0 Direct -100.00% Disposed -84.6% (price as of 2026-08-19)
Sept. 9, 2020 MGNX S 6,924 $27.11 $187,710 0 Direct -100.00% Disposed -84.6% (price as of 2026-08-19)
Oct. 16, 2013 MGNX P 46,875 $16.00 $750,000 46,875 Indirect — Acquired -73.9% (price as of 2026-08-19)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II)

Options, RSUs and convertible securities reported on Form 4 Table II.

Date Ticker Security Underlying Exercise price Expiration Shares A/D
Jan. 12, 2026 ZYME Restricted Stock Unit Common Stock (144,000) — — 144,000 Acquired
Jan. 12, 2026 ZYME Performance Stock Unit Common Stock (222,000) — — 222,000 Acquired
Jan. 12, 2026 ZYME Stock Option (Right to Buy) Common Stock (216,000) $23.16 Jan. 11, 2036 216,000 Acquired
Jan. 12, 2026 ZYME Restricted Stock Unit Common Stock (64,000) — — 64,000 Disposed
Jan. 5, 2026 ZYME Restricted Stock Unit Common Stock (66,666) — — 66,666 Disposed
Jan. 5, 2026 ZYME Restricted Stock Unit Common Stock (47,668) — — 47,668 Disposed
Dec. 22, 2025 ZYME Restricted Stock Unit Common Stock (100,000) — Dec. 22, 2025 100,000 Disposed
Jan. 10, 2025 ZYME Restricted Stock Unit Common Stock (192,000) — — 192,000 Acquired
Jan. 10, 2025 ZYME Stock Option (Right to Buy) Common Stock (288,000) $13.22 Jan. 9, 2035 288,000 Acquired
Jan. 6, 2025 ZYME Restricted Stock Unit Common Stock (66,666) — — 66,666 Disposed
Jan. 6, 2025 ZYME Restricted Stock Unit Common Stock (47,666) — — 47,666 Disposed
Jan. 5, 2024 ZYME Restricted Stock Unit Common Stock (200,000) — — 200,000 Acquired
Jan. 5, 2024 ZYME Stock Option (Right to Buy) Common Stock (300,000) $10.56 Jan. 4, 2034 300,000 Acquired
Jan. 5, 2024 ZYME Restricted Stock Unit Common Stock (47,666) — — 47,666 Disposed
Jan. 5, 2023 ZYME Restricted Stock Unit Common Stock (143,000) — — 143,000 Acquired
Jan. 5, 2023 ZYME Stock Option (Right to Buy) Common Stock (215,000) $8.00 Jan. 4, 2033 215,000 Acquired
Dec. 22, 2022 ZYME Restricted Stock Unit Common Stock (100,000) — Dec. 22, 2025 100,000 Acquired
May 13, 2021 MGNX Stock Option (right to buy) Common Stock (15,000) $28.88 May 13, 2031 15,000 Acquired
Sept. 9, 2020 MGNX Stock Option (right to buy) Common Stock (13,849) $16.00 Oct. 9, 2023 13,849 Disposed
Sept. 9, 2020 MGNX Stock Option (right to buy) Common Stock (6,924) $20.15 June 5, 2024 6,924 Disposed
May 14, 2020 MGNX Stock Option (right to buy) Common Stock (15,000) $24.97 May 14, 2030 15,000 Acquired
May 16, 2019 MGNX Stock Option (right to buy) Common Stock (10,000) $18.00 May 16, 2029 10,000 Acquired
May 17, 2018 MGNX Stock Option (right to buy) Common Stock (10,000) $21.34 May 17, 2028 10,000 Acquired
May 18, 2017 MGNX Stock Option (right to buy) Common Stock (10,000) $19.57 May 18, 2027 10,000 Acquired
May 18, 2016 MGNX Stock Option (right to buy) Common Stock (8,500) $21.06 May 18, 2026 8,500 Acquired
May 20, 2015 MGNX Stock Option (right to buy) Common Stock (8,500) $32.34 May 20, 2015 8,500 Acquired
June 5, 2014 MGNX Stock Option (right to buy) Common Stock (6,924) $20.15 June 5, 2024 6,924 Acquired
Oct. 16, 2013 MGNX Series D-2 Convertible Preferred Warrants Common Stock (15,315) — Oct. 16, 2013 287,533 Disposed
Oct. 16, 2013 MGNX Series D-2 Convertible Preferred Stock Common Stock (204,207) — — 3,833,767 Disposed
Oct. 16, 2013 MGNX Series C Convertible Preferred Stock Common Stock (1,050,652) — — 19,724,839 Disposed
Oct. 9, 2013 MGNX Stock Option (right to buy) Common Stock (13,849) $16.00 Oct. 9, 2023 13,849 Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Initial ownership (Form 3) 3 holdings

Securities held when first becoming an insider, per SEC Form 3.

Date Ticker Security Shares Ownership
Oct. 9, 2013 MGNX Series C Convertible Preferred Stock→ Common Stock (19,724,839) 19,724,839 Indirect
Oct. 9, 2013 MGNX Series D-2 Convertible Preferred Stock→ Common Stock (3,833,767) 3,833,767 Indirect
Oct. 9, 2013 MGNX Series D-2 Convertible Preferred Warrants→ Common Stock — Indirect

Compensation (DEF 14A)

Matched by name from proxy statements (DEF 14A) — verify against the filing.

ZYME

CEO, President & Chair(4)
Fiscal year Salary Bonus Stock awards Option awards Non-equity incentive Pension change Other Total
2024 $654,833 — — — $361,652 — $139,459 $5,253,616
2023 $625,452 — — — $321,651 — $89,146 $3,374,876
2022 $582,481 — — — $537,728 — $81,249 $7,125,457

Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.